Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure

被引：0
|
作者：
Felix Hofer
Niema Kazem
Bernhard Richter
Patrick Sulzgruber
Ronny Schweitzer
Ulrike Pailer
Andreas Hammer
Lorenz Koller
Christian Hengstenberg
Alexander Niessner
机构：
[1] Medical University of Vienna,Department of Internal Medicine II, Division of Cardiology
[2] Vienna Healthcare Group,undefined
来源：
Cardiovascular Drugs and Therapy | 2022年 / 36卷
关键词：
SGLT2i; Diabetes mellitus; Heart failure; Prescription patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：497 / 504
页数：7
相关论文
共 50 条
  • [41] Sodium-glucose cotransporter 2 inhibitors' mechanisms of action in heart failure
    Rotkvic, Petra Grubic
    Berkovic, Maja Cigrovski
    Bulj, Nikola
    Rotkvic, Luka
    Celap, Ivana
    WORLD JOURNAL OF DIABETES, 2020, 11 (07) : 269 - 279
  • [42] Treatment of Heart Failure with Sodium-glucose Cotransporter Type 2 Inhibitors
    Norona, Riber Fabian Donoso
    Martinez, Nairovys Gomez
    Plasencia, Adisnay Rodriguez
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2024, 22 (05): : 982 - 987
  • [43] Sodium-glucose cotransporter 2 inhibitors: efficacious and safe in elderly patients with heart failure
    Patel, Hitesh C.
    Kaye, David M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2305 - 2306
  • [44] Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update
    Profili, Nicia I.
    Castelli, Roberto
    Gidaro, Antonio
    Manetti, Roberto
    Maioli, Margherita
    Delitala, Alessandro P.
    PHARMACEUTICALS, 2024, 17 (11)
  • [45] The gender gap in prescription pattern of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes
    Hammer, A.
    Hofer, F.
    Kazem, N.
    Koller, L.
    Steinacher, E.
    Niessner, A.
    Sulzgruber, P.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2691 - 2691
  • [46] Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis
    Ronen Arbel
    Enis Aboalhasan
    Ariel Hammerman
    Joseph Azuri
    Clinical Drug Investigation, 2020, 40 : 665 - 669
  • [47] Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis
    Arbel, Ronen
    Aboalhasan, Enis
    Hammerman, Ariel
    Azuri, Joseph
    CLINICAL DRUG INVESTIGATION, 2020, 40 (07) : 665 - 669
  • [48] Diving into the unknown: sodium-glucose cotransporter-2 inhibitors in heart failure without diabetes
    Seferovic, Petar M.
    Seferovic, Jelena P.
    Polovina, Marija M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (07) : 874 - 876
  • [49] Evaluation of sodium-glucose cotransporter 2 inhibitors for renal prognosis and mortality in diabetes patients with heart failure on diuretics
    Weng, Yi-Fang
    Chen, Chung-Yu
    Hwang, Shang-Jyh
    Huang, Yaw-Bin
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (04): : 416 - 425
  • [50] Acute natriuretic activity of sodium-glucose cotransporter 2 inhibitor in heart failure patients with type 2 diabetes mellitus
    Fukuoka, S.
    Dohi, K.
    Ishiyama, M.
    Takeuchi, T.
    Fujimoto, N.
    Ito, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3067 - 3067
12345